Trials / Completed
CompletedNCT02497950
HeartMate 3 ELEVATE™ Registry
Evaluating the HeartMate 3™ in a Post-Market Approval Setting: The HeartMate 3 Registry (ELEVATE™)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 540 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Evaluate real-world experience of HeartMate 3 (HM3) in post-approval setting.
Detailed description
The purpose of this post-market registry is to collect data and evaluate the real-world experience of the HeartMate 3 Left Ventricular Assist System (HM3 LVAS) in a post-approval setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HeartMate 3 | Any patient that is determined to meet the HM3 commercially approved labelling indication and that is implanted with the HM3 |
Timeline
- Start date
- 2015-10-13
- Primary completion
- 2019-02-01
- Completion
- 2022-02-28
- First posted
- 2015-07-15
- Last updated
- 2025-03-20
- Results posted
- 2025-03-20
Locations
26 sites across 11 countries: Austria, Czechia, Denmark, Germany, Israel, Italy, Kazakhstan, Netherlands, Poland, Singapore, United Kingdom
Source: ClinicalTrials.gov record NCT02497950. Inclusion in this directory is not an endorsement.